Lista de obras - Kevin ten Haaf - Dominio Público Uruguay

A comparative modeling analysis of risk-based lung cancer screening strategies

artículo científico publicado en 2019

All-cause mortality versus cancer-specific mortality as outcome in cancer screening trials: A review and modeling study

scientific article published on 18 August 2019

Baseline Characteristics and Mortality Outcomes of Control Group Participants and Eligible Non-Responders in the NELSON Lung Cancer Screening Study.

artículo científico publicado en 2015

Clarifying Assumptions and Outcomes in Cost-effectiveness Analyses.

artículo científico publicado en 2016

Clinically detected non-aggressive lung cancers: implications for overdiagnosis and overtreatment in lung cancer screening.

artículo científico publicado en 2018

Comparative analysis of 5 lung cancer natural history and screening models that reproduce outcomes of the NLST and PLCO trials.

artículo científico publicado en 2014

Cost-Effectiveness Analysis of Lung Cancer Screening in the United States: A Comparative Modeling Study

artículo científico publicado en 2019

Cost-effectiveness of low-dose CT screening for lung cancer in a European country with high prevalence of smoking-A modelling study

artículo científico publicado en 2018

Detection of lung cancer through low-dose CT screening (NELSON): a prespecified analysis of screening test performance and interval cancers.

artículo científico publicado en 2014

Development and Validation of a Multivariable Lung Cancer Risk Prediction Model That Includes Low-Dose Computed Tomography Screening Results: A Secondary Analysis of Data From the National Lung Screening Trial

article

Disparities in Receiving Guideline-Concordant Treatment for Lung Cancer in the United States

scientific article published on 01 February 2020

Extrapolation of pre-screening trends: Impact of assumptions on overdiagnosis estimates by mammographic screening.

artículo científico publicado en 2016

Final screening round of the NELSON lung cancer screening trial: the effect of a 2.5-year screening interval

artículo científico publicado en 2016

Low dose CT screening for lung cancer.

artículo científico publicado en 2017

Lung cancer detectability by test, histology, stage, and gender: estimates from the NLST and the PLCO trials

artículo científico publicado en 2014

Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screening

artículo científico publicado en 2014

Lung cancer screening: enhancing risk stratification and minimising harms by incorporating information from screening results

artículo científico publicado en 2019

Lung cancer screening: latest developments and unanswered questions.

artículo científico publicado en 2016

Methods for individualized assessment of absolute risk in case-control studies should be weighted carefully

artículo científico publicado en 2016

Occurrence and lung cancer probability of new solid nodules at incidence screening with low-dose CT: analysis of data from the randomised, controlled NELSON trial.

artículo científico publicado en 2016

Overdiagnosis in lung cancer screening: why modelling is essential

artículo científico publicado en 2015

Performance and Cost-Effectiveness of Computed Tomography Lung Cancer Screening Scenarios in a Population-Based Setting: A Microsimulation Modeling Analysis in Ontario, Canada

artículo científico publicado en 2017

Persisting new nodules in incidence rounds of the NELSON CT lung cancer screening study

scientific article published on 27 December 2018

Quantifying Overdiagnosis in Cancer Screening: A Systematic Review to Evaluate the Methodology.

artículo científico publicado en 2017

Re: Think before you leap.

artículo científico publicado en 2017

Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial

artículo científico publicado en 2020

Risk prediction models for selection of lung cancer screening candidates: A retrospective validation study

artículo científico publicado en 2017

Risk stratification based on screening history: the NELSON lung cancer screening study

artículo científico publicado en 2017

Risk-Targeted Lung Cancer Screening

artículo científico publicado en 2018

Should Never-Smokers at Increased Risk for Lung Cancer Be Screened?

artículo científico publicado en 2015

Targeted screening for lung cancer is here but who do we target and how?

artículo científico publicado en 2020

Treatment capacity required for full-scale implementation of lung cancer screening in the United States

scientific article published on 27 February 2019

Trends in lung cancer risk and screening eligibility affect overdiagnosis estimates

artículo científico publicado en 2019

Uptake of minimally invasive surgery and stereotactic body radiation therapy for early stage non-small cell lung cancer in the USA: an ecological study of secular trends using the National Cancer Database

artículo científico publicado en 2020

Lista de obras de Kevin ten Haaf

A comparative modeling analysis of risk-based lung cancer screening strategies

All-cause mortality versus cancer-specific mortality as outcome in cancer screening trials: A review and modeling study

Baseline Characteristics and Mortality Outcomes of Control Group Participants and Eligible Non-Responders in the NELSON Lung Cancer Screening Study.

Clarifying Assumptions and Outcomes in Cost-effectiveness Analyses.

Clinically detected non-aggressive lung cancers: implications for overdiagnosis and overtreatment in lung cancer screening.

Comparative analysis of 5 lung cancer natural history and screening models that reproduce outcomes of the NLST and PLCO trials.

Cost-Effectiveness Analysis of Lung Cancer Screening in the United States: A Comparative Modeling Study

Cost-effectiveness of low-dose CT screening for lung cancer in a European country with high prevalence of smoking-A modelling study

Detection of lung cancer through low-dose CT screening (NELSON): a prespecified analysis of screening test performance and interval cancers.

Development and Validation of a Multivariable Lung Cancer Risk Prediction Model That Includes Low-Dose Computed Tomography Screening Results: A Secondary Analysis of Data From the National Lung Screening Trial

Disparities in Receiving Guideline-Concordant Treatment for Lung Cancer in the United States

Extrapolation of pre-screening trends: Impact of assumptions on overdiagnosis estimates by mammographic screening.

Final screening round of the NELSON lung cancer screening trial: the effect of a 2.5-year screening interval

Low dose CT screening for lung cancer.

Lung cancer detectability by test, histology, stage, and gender: estimates from the NLST and the PLCO trials

Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screening

Lung cancer screening: enhancing risk stratification and minimising harms by incorporating information from screening results

Lung cancer screening: latest developments and unanswered questions.

Methods for individualized assessment of absolute risk in case-control studies should be weighted carefully

Occurrence and lung cancer probability of new solid nodules at incidence screening with low-dose CT: analysis of data from the randomised, controlled NELSON trial.

Overdiagnosis in lung cancer screening: why modelling is essential

Performance and Cost-Effectiveness of Computed Tomography Lung Cancer Screening Scenarios in a Population-Based Setting: A Microsimulation Modeling Analysis in Ontario, Canada

Persisting new nodules in incidence rounds of the NELSON CT lung cancer screening study

Quantifying Overdiagnosis in Cancer Screening: A Systematic Review to Evaluate the Methodology.

Re: Think before you leap.

Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial

Risk prediction models for selection of lung cancer screening candidates: A retrospective validation study

Risk stratification based on screening history: the NELSON lung cancer screening study

Risk-Targeted Lung Cancer Screening

Should Never-Smokers at Increased Risk for Lung Cancer Be Screened?

Targeted screening for lung cancer is here but who do we target and how?

Treatment capacity required for full-scale implementation of lung cancer screening in the United States

Trends in lung cancer risk and screening eligibility affect overdiagnosis estimates

Uptake of minimally invasive surgery and stereotactic body radiation therapy for early stage non-small cell lung cancer in the USA: an ecological study of secular trends using the National Cancer Database